These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25377151)

  • 1. Paliperidone for the treatment of ketamine-induced psychosis: a case report.
    Zuccoli ML; Muscella A; Fucile C; Carrozzino R; Mattioli F; Martelli A; Orengo S
    Int J Psychiatry Med; 2014; 48(2):103-8. PubMed ID: 25377151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of phencyclidine-associated psychosis with ECT.
    Grover D; Yeragani VK; Keshavan MS
    J Clin Psychiatry; 1986 Sep; 47(9):477-8. PubMed ID: 3745132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.
    Marder SR; Kramer M; Ford L; Eerdekens E; Lim P; Eerdekens M; Lowy A
    Biol Psychiatry; 2007 Dec; 62(12):1363-70. PubMed ID: 17601495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ketamine in normal and schizophrenic volunteers.
    Lahti AC; Weiler MA; Tamara Michaelidis BA; Parwani A; Tamminga CA
    Neuropsychopharmacology; 2001 Oct; 25(4):455-67. PubMed ID: 11557159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia.
    Luthringer R; Staner L; Noel N; Muzet M; Gassmann-Mayer C; Talluri K; Cleton A; Eerdekens M; Battisti WP; Palumbo JM
    Int Clin Psychopharmacol; 2007 Sep; 22(5):299-308. PubMed ID: 17690599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report.
    Grunze H; Gallinat J; Haag C; Hegerl U
    Schizophr Res; 2000 Jan; 41(2):386-8. PubMed ID: 10708350
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine and phencyclidine-associated psychosis: three case reports.
    Berlant JL
    J Clin Psychiatry; 1985 Dec; 46(12):542-4. PubMed ID: 2866179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of ECT in phencyclidine-induced psychosis.
    Rosen AM; Mukherjee S; Shinbach K
    J Clin Psychiatry; 1984 May; 45(5):220-2. PubMed ID: 6144671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia.
    Canuso CM; Bossie CA; Amatniek J; Turkoz I; Pandina G; Cornblatt B
    Early Interv Psychiatry; 2010 Feb; 4(1):64-78. PubMed ID: 20199482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-induced psychosis: eight-year follow-up of ten cases.
    Wright HH; Cole EA; Batey SR; Hanna K
    South Med J; 1988 May; 81(5):565-7. PubMed ID: 3368805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine associated psychedelic effects and dependence.
    Lim DK
    Singapore Med J; 2003 Jan; 44(1):31-4. PubMed ID: 12762561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.
    Yoon KS; Park TW; Yang JC; Kim MG; Oh KY; Park MS; Chung YC
    Hum Psychopharmacol; 2012 May; 27(3):305-14. PubMed ID: 22585590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
    Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
    [No Abstract]   [Full Text] [Related]  

  • 17. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.
    Jones A
    J Psychiatr Ment Health Nurs; 2008 Dec; 15(10):792-9. PubMed ID: 19012670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine psychosis masquerading as PCP: a case report.
    Collins GB; McAllister MS
    J Psychoactive Drugs; 2008 Jun; 40(2):211-4. PubMed ID: 18720672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies.
    Emsley R; Berwaerts J; Eerdekens M; Kramer M; Lane R; Lim P; Hough D; Palumbo J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):343-56. PubMed ID: 18854723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine as a street drug.
    Stewart CE
    Emerg Med Serv; 2001 Nov; 30(11):30, 32, 34 passim. PubMed ID: 11759641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.